Skip to main content
Premium Trial:

Request an Annual Quote

Timothy Stout, Mark Caulfield, Tim Aitman, Alan Ashworth, Aroon Hingorani, Ellen Solomon, Brendan Wren, Nick Carter, Shirley Hodgson, Nina Fedoroff, Richard Zakour

Premium
Oregon Health and Science University said last week that Timothy Stout has been appointed to the newly created position of vice president for commercialization strategies, effective Sept. 1.
 
Stout is currently an associate professor of ophthalmology at the OHSU Casey Eye Institute. Stout holds a PhD in molecular genetics and MD from Baylor College of Medicine. He completed an internship in general pediatrics at Houston’s Texas Children’s Hospital, and was a fellow in human genetics at Baylor. He completed his ophthalmology residency at Doheny Eye Hopsital at the University of Southern California, and a retina fellowship at Moorfields Eye Hopsital in London. He also holds an MBA from the Oregon Executive MBA program.
 
OHSU said that Stout will report to OHSU executive vice president Steve Stadum, and will work closely with Daniel Dorsa, OHSU’s vice president for research, and with the Office of Technology and Research Collaborations, headed by Arundeep Pradhan.
 

 
London Genetics, a company that facilitates and manages partnerships between the healthcare industry and London-based centers of excellence in genomics-based medical research, last week announced the formation of its scientific advisory board.
 
The board will be chaired by Mark Caulfield, professor of clinical pharmacology at Queen Mary, University of London. The board will also include:
  • Tim Aitman, professor of clinical and molecular genetics, Imperial College London
  • Alan Ashworth, director, Breakthrough Breast Cancer Research Center, Institute of Cancer Research
  • Aroon Hingorani, British Heart Foundation senior research fellow, division of medicine, University College, London
  • Ellen Solomon, head, medical and molecular genetics, King’s College London
  • Brendan Wren, head of pathogen molecular biology, London School of Hygiene and Tropical Medicine
  • Nick Carter, head of clinical developmental sciences, St. George’s, University of London
  • Shirley Hodgson, professor, cancer genetics, St. George’s, University of London

 
Nina Fedoroff, a former Sigma-Aldrich director and Penn State University professor, has been named science and technology adviser to US Secretary of State Condoleezza Rice.
 
Fedoroff was nominated for the post by the National Academy of Sciences. She resigned from her spot on Sigma-Aldrich’s board, but remains chair of the life sciences and an Evan Pugh professor at Penn State.
 

 
The Tech Council of Maryland has tapped Richard Zakour to be executive director of MdBio and the MdBio Foundation.
 
Zakour was formerly general manager of Fisher BioSciences and previously was in management at McKesson Clinical Consulting Services, DynCorp, and Cambridge Biotech. Zakour was a member of TCM’s board of directors between 2003 until early 2007 and he served on MdBio Foundation’s board as well.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.